NEXGEL, Inc. (NXGL) News
Track canonical SquawkNews coverage tagged to NXGL, NEXGEL, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 7 indexed stories across 6 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
NexGel begins using strategic review presentation on proposed platform reorganization
NexGel began using a new shareholder presentation titled “Strategic Review & Proposed Platform Reorganization.”Key Highlights:Original SEC Filing: NEXGEL, INC. [ NXGL ] - 8-K - Sep. 24, 2026This is an AI-powered summary.
REGULATION | Sep 24, 2026, 08:23 PM UTC
L
NEXGEL Announces Dial-In Details for Investor Update Call
LANGHORNE, Pa., Sept. 23, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a company with a patient centric medical technology sales and marketing team working closely with clinicians t
NEWS | Sep 23, 2026, 01:32 PM UTC
L
NXGL downgraded to Hold at Maxim Group
NXGL is downgraded from Buy to Hold at Maxim Group, with no catalyst supplied in the alert.
EQUITY | Aug 24, 2026, 11:59 AM UTC
M
NXGL, OPTT and USAU launch strategic reviews
NEXGEL, Ocean Power Technologies and U.S. Gold Corp. each said they are reviewing strategic alternatives, with NXGL targeting an initial plan in 30 to 45 days.
MNA | Aug 21, 2026, 05:25 PM UTC
L
NY Empire State Manufacturing Index Rises to 20.6 in August
The New York Fed's Empire State Manufacturing Index surged to 20.6 in August from 15.6 in the prior month, topping market estimates of 11.
EARNINGS | Aug 17, 2026, 04:04 PM UTC
L
Empire State Manufacturing Index jumps to 20.6 in August
The New York Fed’s Empire State Manufacturing Index rises to 20.6 in August from 15.6 in the prior month, exceeding market estimates of 11, as U.S. stocks trade mixed.
EARNINGS | Aug 17, 2026, 01:39 PM UTC
L
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Alzamend Neuro (NASDAQ: ALZN ) stock increased by 12.9% to $1.35 during Tuesday's after-market session. The company's market cap stands at $4.4 million. Vivos Therapeutics (NASDAQ: VVOS ) shares increased by 9.92
GEOPOLITICS | Jun 30, 2026, 09:05 PM UTC